Hospital Mortality in the United States following Acute Kidney Injury

Author:

Brown Jeremiah R.123ORCID,Rezaee Michael E.14,Marshall Emily J.1,Matheny Michael E.5678

Affiliation:

1. The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Lebanon, NH 03756, USA

2. Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA

3. Department of Community and Family Medicine, Lebanon, NH 03756, USA

4. Oakland University William Beaumont School of Medicine, Rochester, MI 48309, USA

5. Geriatrics Research Education & Clinical Center (GRECC), Tennessee Valley Healthcare System (TVHS), Veterans Health Administration, Nashville, TN 37232, USA

6. Division of General Internal Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA

7. Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA

8. Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA

Abstract

Acute kidney injury (AKI) is a common reason for hospital admission and complication of many inpatient procedures. The temporal incidence of AKI and the association of AKI admissions with in-hospital mortality are a growing problem in the world today. In this review, we discuss the epidemiology of AKI and its association with in-hospital mortality in the United States. AKI has been growing at a rate of 14% per year since 2001. However, the in-hospital mortality associated with AKI has been on the decline starting with 21.9% in 2001 to 9.1 in 2011, even though the number of AKI-related in-hospital deaths increased almost twofold from 147,943 to 285,768 deaths. We discuss the importance of the 71% reduction in AKI-related mortality among hospitalized patients in the United States and draw on the discussion of whether or not this is a phenomenon of hospital billing (coding) or improvements to the management of AKI.

Funder

Agency for Healthcare Research and Quality

Publisher

Hindawi Limited

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3